TY - JOUR
T1 - Relationship between pulmonary function and peripheral vascular function in older Chinese
T2 - Guangzhou biobank cohort study-CVD
AU - Pan, Jing
AU - Xu, Lin
AU - Lam, Tai Hing
AU - Jiang, Chao Qiang
AU - Zhang, Wei Sen
AU - Zhu, Feng
AU - Jin, Ya Li
AU - Neil Thomas, G.
AU - Cheng, Kar Keung
AU - Adab, Peymane
N1 - Publisher Copyright:
© 2018 The Author(s).
PY - 2018/5/21
Y1 - 2018/5/21
N2 - Background: Findings describing the relationship between pulmonary function and peripheral vascular function have been inconclusive. We explored this relationship in Guangzhou Biobank Cohort Study-Cardiovascular Subcohort (GBCS-CVD). Methods: Brachial-ankle pulse wave velocity (baPWV) and ankle brachial index (ABI) were measured by a waveform analyser, and pulmonary function by turbine flowmeter spirometry. Predicted forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC) were derived using equations for Chinese. Regression analyses were used to investigate the association. Results: Of 1528 older Chinese, 980 (64.1%) had arterial stiffness (baPWV ≥1400 cm/s), but only 29 (1.9%) had peripheral arterial disease (PAD) (ABI <0.9). The mean (±standard deviation, SD) baPWV was 1547 (±298) cm/s and mean (±SD) ABI 1.09 (±0.09). Before and after adjusting for potential confounders, baPWV was negatively associated with FEV1 and FVC % predicted (% predicted=observed/predicted ×100%) (adjusted β: -0.95 and-1.16 respectively, p<0.05), and ABI was marginally non-significantly positively associated with FEV1% predicted (adjusted β 0.02, p=0.32) and FVC% predicted (adjusted β 0.02, p=0.18). Compared to participants in the highest tertile of pulmonary function, those in the lowest had higher risk of arterial stiffness (adjusted odds ratio (AOR) 1.51, 95% CI 1.09-2.10 for FEV1 and AOR 1.69, 95% CI 1.22-2.33 for FVC), but the higher risk of PAD was marginally non-significant (AOR 1.64, p=0.42 for FEV1 and AOR 1.65, p=0.24 for FVC). Conclusion: In older relatively healthy normal weight Chinese, pulmonary function was inversely dose-dependently associated with arterial stiffness, while the association with PAD was much weaker.
AB - Background: Findings describing the relationship between pulmonary function and peripheral vascular function have been inconclusive. We explored this relationship in Guangzhou Biobank Cohort Study-Cardiovascular Subcohort (GBCS-CVD). Methods: Brachial-ankle pulse wave velocity (baPWV) and ankle brachial index (ABI) were measured by a waveform analyser, and pulmonary function by turbine flowmeter spirometry. Predicted forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC) were derived using equations for Chinese. Regression analyses were used to investigate the association. Results: Of 1528 older Chinese, 980 (64.1%) had arterial stiffness (baPWV ≥1400 cm/s), but only 29 (1.9%) had peripheral arterial disease (PAD) (ABI <0.9). The mean (±standard deviation, SD) baPWV was 1547 (±298) cm/s and mean (±SD) ABI 1.09 (±0.09). Before and after adjusting for potential confounders, baPWV was negatively associated with FEV1 and FVC % predicted (% predicted=observed/predicted ×100%) (adjusted β: -0.95 and-1.16 respectively, p<0.05), and ABI was marginally non-significantly positively associated with FEV1% predicted (adjusted β 0.02, p=0.32) and FVC% predicted (adjusted β 0.02, p=0.18). Compared to participants in the highest tertile of pulmonary function, those in the lowest had higher risk of arterial stiffness (adjusted odds ratio (AOR) 1.51, 95% CI 1.09-2.10 for FEV1 and AOR 1.69, 95% CI 1.22-2.33 for FVC), but the higher risk of PAD was marginally non-significant (AOR 1.64, p=0.42 for FEV1 and AOR 1.65, p=0.24 for FVC). Conclusion: In older relatively healthy normal weight Chinese, pulmonary function was inversely dose-dependently associated with arterial stiffness, while the association with PAD was much weaker.
KW - Arterial stiffness
KW - Peripheral arterial disease (PAD)
KW - Pulmonary function
KW - Vascular function
UR - http://www.scopus.com/inward/record.url?scp=85047373051&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85047373051&partnerID=8YFLogxK
U2 - 10.1186/s12890-018-0649-x
DO - 10.1186/s12890-018-0649-x
M3 - Article
C2 - 29783975
AN - SCOPUS:85047373051
SN - 1471-2466
VL - 18
JO - BMC Pulmonary Medicine
JF - BMC Pulmonary Medicine
IS - 1
M1 - 74
ER -